The HSD3B1 gene provides instructions for an enzyme (a protein that helps chemical reactions happen) that turns hormone building blocks into steroid hormones, so variants that change its activity can shift testosterone and estrogen related hormone levels. This gene plays an important role in tissues such as the prostate, breast, skin, and placenta. Some versions of the HSD3B1 gene are linked to how the body uses adrenal hormones and may influence prostate cancer behavior and response to hormone lowering treatment. HSD3B1 is better known in medical research than in popular culture.
What is a gene?
Genes are sections of DNA that hold instructions cells use to make molecules or manage activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how your body grows and works, and they can influence how you react to food, stress, or medications. More detail on this topic is available in the LearnHub.
Overview
HSD3B1Gene function
What if the gene works
The HSD3B1 gene helps certain tissues make steroid hormones from hormone building blocks. This supports normal hormone balance, including sex hormones that affect puberty, fertility, and body hair.
Risk
What if the gene does not work
Milder to more severe variants in the HSD3B1 gene can reduce how well cells make this steroid processing enzyme. That may weaken steps in converting hormone building blocks into progesterone, androgens, and other steroids in peripheral tissues and the placenta.
Treatment
What does that mean for your treatment
No treatment choice is currently guided by pathogenic variants in the HSD3B1 gene in routine clinical guidelines. The HSD3B1 gene is being studied as a biomarker of response and resistance to hormone blocking treatments in prostate cancer, but this has not yet become standard care.
Gene function
What if the gene works
In plain terms, the HSD3B1 gene’s main function is steroid hormone production, which supports stress response, salt balance, reproduction, and pregnancy. The protein it makes changes early hormone starter molecules into forms your cells can use to build key hormones. This is a routine, essential step in normal hormone chemistry.
The protein from the HSD3B1 gene changes early steroid starter molecules into the next forms needed for hormone building. This step helps cells move from raw materials toward hormones such as progesterone and other sex hormone starters.
By creating these next-step molecules, HSD3B1 supports the body’s ability to make several steroid hormones. These pathways help produce hormones involved in reproduction, pregnancy, salt balance, and the stress response.
Many tissues use HSD3B1 to process hormone starters into forms that can be used locally. This helps different parts of the body adjust steroid hormone production to their routine needs.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the HSD3B1 gene can change how much of its enzyme is made, how stable it is, or how well it handles starter hormone molecules. For example, HSD3B1 c.1245A>C can make the enzyme harder for cells to break down, so it stays active longer. Research on how HSD3B1 variants affect enzyme activity shows a range from milder changes to more disruptive ones that sharply lower or nearly abolish this hormone processing step.
How variants are linked to conditions
Variants in the HSD3B1 gene are most consistently linked to differences in prostate cancer outcomes rather than to a single inherited syndrome. The common c.1245A>C variant has been associated with earlier progression during treatment that lowers testosterone and with survival differences in some groups, so HSD3B1 gene variants and prostate cancer outcomes remain a clinically relevant area of study. These associations describe risk trends in populations and do not predict an individual person’s course with certainty.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal part of human biology. Most do not directly affect health and simply reflect natural differences among people. For many genes, having a variant connected with a condition points to a possible association rather than a definite diagnosis, particularly when more than one gene and environmental factors play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For HSD3B1, risk can vary depending on which gene change is present and the health condition being considered. The clearest evidence is in some hormone-related conditions, especially prostate cancer, where certain inherited versions of HSD3B1 can affect risk of cancer growth or return during hormone-lowering treatment. Anyone concerned about personal risk should discuss their family history and test results with a doctor or genetic counselor.
Inheritance of HSD3B1 variants
There is not yet a broadly confirmed Mendelian inheritance pattern for HSD3B1-related health effects, because most well-known HSD3B1 variants are discussed as risk-influencing changes rather than a single inherited condition with a fixed pattern. In practice, how HSD3B1 variants are inherited follows the usual rules for genes on the nonsex chromosomes: the HSD3B1 gene is located on chromosome 1, so you inherit one copy from your mother and one copy from your father. This means sons and daughters can inherit HSD3B1 variants in the same way.
What does my HSD3B1 result mean for my family?
There is not yet a broadly confirmed, condition-specific family inheritance pattern for HSD3B1 in the way there is for some single-gene conditions. Some HSD3B1 results are linked more to changes in risk or treatment response than to a clear inherited condition, so what it means for relatives depends on the exact result.
Genetic information
Genetic testing
How you find out about variants
To look for variants, HSD3B1 genetic testing uses a saliva sample or blood draw. A lab reads the DNA in the HSD3B1 gene to check whether you carry a specific change. Results show which variant is present, but they do not by themselves predict exactly how your health will be affected.
When should I consider getting a genetic test?
There is not yet a widely established reason for most people to have genetic testing just for the HSD3B1 gene. In some people being treated for prostate cancer, this gene may come up as part of a broader test, and the decision is best made with a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal varies by the condition and by the type of variant involved. Lifestyle, environment, age, and medical history, among other factors, also shape how the body functions over time. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most helpful when viewed together with other parts of care. In other situations, a genetic result may give a clear answer. For medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. Part of the difference comes from how the body absorbs, breaks down, transports, or responds to a drug. These differences are common and can influence both how well a medicine works and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. By looking at the relationship between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support more informed and individualized treatment decisions. If you want to look into this topic more closely, you can learn more in the LearnHub.
Drugs influenced by the HSD3B1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication decisions, so general questions about medicines or side effects are best discussed with your doctor. Some studies suggest HSD3B1 may affect how some people with prostate cancer respond to hormone-blocking treatment, but this is still a specialist discussion rather than standard care.
History
Research on the HSD3B1 gene grew out of mid 20th century work on how the body makes steroid hormones. Initially understood only through visible traits, later recognized as tied to a specific gene, this pathway became clearer as enzyme studies advanced. In the 1990s, scientists identified HSD3B1 as one of two closely related human genes in this family, helping separate its role from the HSD3B2 gene. From these first observations, research expanded steadily. Later studies connected inherited variants in this gene family to conditions affecting adrenal and sex hormone production. In more recent years, HSD3B1 gained added attention in prostate cancer research because some variants were linked to differences in how tumors use hormone pathways during treatment.